104 related articles for article (PubMed ID: 3249326)
21. Tumor necrosis factor-induced necrosis: a monocyte-mediated hypercoagulable effect.
Spillert CR; Sun S; Ponnudurai R; Miller MA; Lazaro EJ
J Natl Med Assoc; 1995 Jul; 87(7):508-9. PubMed ID: 7636898
[TBL] [Abstract][Full Text] [Related]
22. An assessment of monocyte procoagulant activity in patients with solid tumors.
Dasmahapatra KS; Cheung NK; Spillert C; Lazaro E
J Surg Res; 1987 Aug; 43(2):158-63. PubMed ID: 3626537
[TBL] [Abstract][Full Text] [Related]
23. [Study of blood copper and iron in women with benign or malignant breast diseases].
Le Borgne de Kaouel C; Aubert C; Juret P
Pathol Biol; 1968 Jan; 16(1):85-6. PubMed ID: 4869424
[No Abstract] [Full Text] [Related]
24. [Dynamics of gonadotropins and prolactin in dysplasias and cancer of the breast].
Korolev VI; Skliar SIu; Ponomarev IN
Vrach Delo; 1988 Jan; (1):59-61. PubMed ID: 3363942
[No Abstract] [Full Text] [Related]
25. Usefulness of serum CA-15.3 in the management of benign breast lesion.
Mondal HP; Roy H; Mondal P; Saha M; Basu N
J Indian Med Assoc; 2012 Apr; 110(4):242-4. PubMed ID: 23025224
[TBL] [Abstract][Full Text] [Related]
26. [Plasma-prolactin concentrations in breast cancer at various stages, in mastopathy and other malignant tumors].
Holtkamp W; von Heyden D; Rauschecker H; Nagel GA
Schweiz Med Wochenschr; 1983 Oct; 113(41):1513-20. PubMed ID: 6635641
[TBL] [Abstract][Full Text] [Related]
27. [Changes in serum alpha 1-antitrypsin in benign and malignant breast diseases].
Millán Núñez-Cortés J; Senra Varela A
Med Clin (Barc); 1984 Mar; 82(8):347-8. PubMed ID: 6609289
[No Abstract] [Full Text] [Related]
28. [Plasma levels of prolactin in women with dysplasia and tumors of the breast (fibroadenoma and carcinoma of the breast)].
Iturburu Belmonte IM; Basáñez Amuchastegui A; Jiménez Jiménez E; López de Tejada Cabeza I; Goicoechea García J; Méndez Martín J
Rev Quir Esp; 1988; 15(1):17-21. PubMed ID: 3153353
[No Abstract] [Full Text] [Related]
29. Procoagulant activity in bronchoalveolar lavage in the adult respiratory distress syndrome. Contribution of tissue factor associated with factor VII.
Idell S; Gonzalez K; Bradford H; MacArthur CK; Fein AM; Maunder RJ; Garcia JG; Griffith DE; Weiland J; Martin TR
Am Rev Respir Dis; 1987 Dec; 136(6):1466-74. PubMed ID: 3688650
[TBL] [Abstract][Full Text] [Related]
30. Modified recalcification time: a global coagulation screening test.
Spillert CR; Lazaro EJ
J Natl Med Assoc; 1993 Aug; 85(8):611-6. PubMed ID: 8371283
[TBL] [Abstract][Full Text] [Related]
31. Contribution of the monocyte to thrombotic potential.
Spillert CR; Lazaro EJ
Agents Actions; 1991 Sep; 34(1-2):28-9. PubMed ID: 1793044
[TBL] [Abstract][Full Text] [Related]
32. Tissue factor over-expression by human pancreatic cancer cells BXPC3 is related to higher prothrombotic potential as compared to breast cancer cells MCF7.
Gerotziafas GT; Galea V; Mbemba E; Khaterchi A; Sassi M; Baccouche H; Prengel C; van Dreden P; Hatmi M; Bernaudin JF; Elalamy I
Thromb Res; 2012 Jun; 129(6):779-86. PubMed ID: 21917301
[TBL] [Abstract][Full Text] [Related]
33. [Clinical aspects of the radioimmunoassay of carcinoembryonic antigen levels in breast cancer].
Agranat VZ; Baliura AV; Nikogosian GA; Smolina TA; Iass NIa
Med Radiol (Mosk); 1983 Aug; 28(8):34-7. PubMed ID: 6888209
[TBL] [Abstract][Full Text] [Related]
34. Circadian mesor-hyperprolactinemia in fibrocystic mastopathy.
Tarquini B; Gheri R; Romano S; Costa A; Cagnoni M; Lee JK; Halberg F
Am J Med; 1979 Feb; 66(2):229-37. PubMed ID: 425966
[No Abstract] [Full Text] [Related]
35. Plasma isoflavones and fibrocystic breast conditions and breast cancer among women in Shanghai, China.
Lampe JW; Nishino Y; Ray RM; Wu C; Li W; Lin MG; Gao DL; Hu Y; Shannon J; Stalsberg H; Porter PL; Frankenfeld CL; Wähälä K; Thomas DB
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2579-86. PubMed ID: 18086761
[TBL] [Abstract][Full Text] [Related]
36. [Tissue polypeptide and carcinoembryonic antigens in patients with breast cancer].
Polevaia EB; Tkacheva GA; Ivanov VM; Koposova TL
Vopr Onkol; 1984; 30(3):9-13. PubMed ID: 6710954
[TBL] [Abstract][Full Text] [Related]
37. Western blotting and enzymatic activity analysis of cathepsin D in breast tissue and sera of patients with breast cancer and benign breast disease and of normal controls.
Schultz DC; Bazel S; Wright LM; Tucker S; Lange MK; Tachovsky T; Longo S; Niedbala S; Alhadeff JA
Cancer Res; 1994 Jan; 54(1):48-54. PubMed ID: 8261461
[TBL] [Abstract][Full Text] [Related]
38. [Determination of blood prolactin levels in breast diseases using prolactin radioimmunoassay kits (CIS-Prolak Kit)].
Nakajima K; Saito K; Tobioka M; Ishihara K; Kobayashi T
Horumon To Rinsho; 1976 Dec; 24(12):1303-10. PubMed ID: 1035518
[No Abstract] [Full Text] [Related]
39. Modified recalcification time (MRT): a sensitive cancer test? Review of the evidence.
Spillert CR; Lazaro EJ
J Natl Med Assoc; 1995 Sep; 87(9):687-92. PubMed ID: 9583965
[TBL] [Abstract][Full Text] [Related]
40. Cystic tumours of the breast.
Payne RA; Jackson DB
Ann R Coll Surg Engl; 1980 May; 62(3):228-9. PubMed ID: 7396351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
